SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year. 

Bill & Melinda Gates Foundation

Google Ventures

Oxford Science Enterprises

Braavos Investment Advisers

The Future Fund

Oxford Investment Consultants LLP

SpyBiotech

Brii Biosciences is a competitor of SpyBiotech in the biotechnology industry. They focus on developing innovative therapies for infectious diseases.

Brii Biosciences

Gritstone Oncology is a competitor of SpyBiotech in the biotechnology industry. They specialize in developing cancer immunotherapies.

Gritstone Oncology

Dermavant Sciences is identified as a competitor of SpyBiotech. They are involved in the development of dermatological therapies.

Dermavant Sciences

Metrum Research Group is a competitor of SpyBiotech in the biotechnology industry. They provide scientific consulting services for drug development.

Metrum Research Group

Clovis Oncology is a competitor of SpyBiotech in the biotechnology industry. They focus on developing innovative cancer treatments.

Clovis Oncology

ONI is identified as a competitor of SpyBiotech. They are involved in the biotechnology industry, although specific details on their focus are not available.

Numab is listed as a possible competitor to SpyBiotech. They operate in the biotechnology industry, but specific details on their focus are not provided.

Numab

Refeyn is mentioned as a potential competitor to SpyBiotech. However, specific details about their operations and focus are not available.

Refeyn

SpyBiotech is a UK-based biotechnology company that specializes in the development of vaccines and immunotherapies. The company's platform technology, SpyTag/SpyCatcher, enables the rapid production of vaccines and has applications in oncology, infectious diseases, and other therapeutic areas. SpyBiotech collaborates with academic institutions and pharmaceutical companies to advance vaccine research and development.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jun 20, 2024 11:35 AM	71f17488
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 20, 2024 1:17 PM	db3d80a3
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jun 20, 2024 11:35 AM	abff1399
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 20, 2024 11:35 AM	c01192f9
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:SPYBIOTECH

SpyBiotech